Ausgabe 4/2019
Annual Review Issue: Cancer immunology, inflammation and tolerance
Inhalt (10 Artikel)
Cancer immunology, inflammation, and tolerance: an introduction
Stefan Dirnhofer, Alfred Zippelius
Immunosuppressive circuits in tumor microenvironment and their influence on cancer treatment efficacy
Alessandra Tuccitto, Eriomina Shahaj, Elisabetta Vergani, Simona Ferro, Veronica Huber, Monica Rodolfo, Chiara Castelli, Licia Rivoltini, Viviana Vallacchi
Recent success and limitations of immune checkpoint inhibitors for cancer: a lesson from melanoma
Margaret Ottaviano, Sabino De Placido, Paolo Antonio Ascierto
Rational combination of cancer immunotherapy in melanoma
Mario Mandalà, Piotr Rutkowski
Adoptive cellular therapies: the current landscape
Maartje W. Rohaan, Sofie Wilgenhof, John B. A. G. Haanen
Integrating histopathology, immune biomarkers, and molecular subgroups in solid cancer: the next step in precision oncology
Nicolas A. Giraldo, J. David Peske, Catherine Sautès-Fridman, Wolf H. Fridman
Predictive potential and need for standardization of PD-L1 immunohistochemistry
Spasenija Savic Prince, Lukas Bubendorf
Immune tumor board: integral part in the multidisciplinary management of cancer patients treated with cancer immunotherapy
Heinz Läubli, Stefan Dirnhofer, Alfred Zippelius
Genetic alterations of 9p24 in lymphomas and their impact for cancer (immuno-)therapy
Thomas Menter, Alexandar Tzankov
Precision immunoprofiling by image analysis and artificial intelligence
Viktor H. Koelzer, Korsuk Sirinukunwattana, Jens Rittscher, Kirsten D. Mertz